These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9425720)

  • 1. Fasting/refeeding enhances the crypt multiplicity in rat colon carcinogenesis induced by azoxymethane.
    Premoselli F; Sesca E; Chiara M; Binasco V; Tessitore L
    Boll Soc Ital Biol Sper; 1996; 72(9-10):239-45. PubMed ID: 9425720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon cancer is induced by a single low dose of azoxymethane in fasted-refed rats.
    Caderni G; Bollito E; Tessitore L
    Nutr Cancer; 1999; 35(2):137-42. PubMed ID: 10693167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
    Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
    Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
    Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death and cell proliferation contribute to the enhanced growth of foci by fasting in rat medial colon.
    Premoselli F; Sesca E; Binasco V; Franchino C; Tessitore L
    Boll Soc Ital Biol Sper; 1997; 73(3-4):71-6. PubMed ID: 9540235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying effect of dietary lipids and azoxymethane on early stages of colon carcinogenesis: enumeration of aberrant crypt foci and proliferative indices.
    Bird RP; Lafave LM
    Cancer Detect Prev; 1995; 19(4):308-15. PubMed ID: 7553672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
    Shih CK; Chiang W; Kuo ML
    Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
    Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
    Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced growth of colorectal aberrant crypt foci in fasted/refed rats involves changes in TGFbeta1 and p21CIP expressions.
    Caderni G; Perrelli MG; Cecchini F; Tessitore L
    Carcinogenesis; 2002 Feb; 23(2):323-7. PubMed ID: 11872640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats.
    Parnaud G; Taché S; Peiffer G; Corpet DE
    Cancer Res; 1999 Oct; 59(20):5143-7. PubMed ID: 10537289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J; Patlolla JM; Swamy MV; Rao CV
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis.
    Caderni G; Femia AP; Giannini A; Favuzza A; Luceri C; Salvadori M; Dolara P
    Cancer Res; 2003 May; 63(10):2388-92. PubMed ID: 12750256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.